Figure this one out. Here's the latest institutional ownership numbers from Fidelity...



Price on 2/28/2025: $0.3072 Health Care Sector
Market Capitalization: $375.7 M Biotechnology Industry
Business Description Data provided by S&P Compustat

CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of
treatments for multiple therapeutic indications.

Key Statistics
Employee Count 9
Institutional Ownership 0.0%
Total Revenue (TTM) $0.00
11/30/2024
Revenue Growth
(TTM vs. Prior TTM)
--
Enterprise Value $383.1 M
2/28/2025